Question 1

Who owns SCNI?

Accepted Answer

SCINAI IMMUNOTHERAPEUTICS LT SPONSO (SCNI) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Question 2

Are institutions buying or selling SCNI?

Accepted Answer

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for SCINAI IMMUNOTHERAPEUTICS LT SPONSO, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

Question 3

What is the Smart Money Verdict on SCNI?

Accepted Answer

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for SCINAI IMMUNOTHERAPEUTICS LT SPONSO.

Question 4

Is institutional money flowing into SCNI?

Accepted Answer

7 institutional investors hold SCINAI IMMUNOTHERAPEUTICS LT SPONSO (SCNI). View detailed buyer/seller breakdown on HoldingsIntel.

Question 5

What do hedge funds think about SCNI?

Accepted Answer

Track institutional sentiment and conviction scores for SCINAI IMMUNOTHERAPEUTICS LT SPONSO (SCNI) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
CITADEL ADVISORS LLC	Increased	34,562(+20.7%)	$24,612	0.0%	-45.95%	16
XTX Topco Ltd	New	27,294	$19,436	0.0%	+11.11%	26
Virtu Financial LLC	New	15,409	$11,000	0.0%	+11.11%	24
RHUMBLINE ADVISERS	Decreased	1,878(-47.1%)	$1,335	0.0%	-83.13%	0
UBS Group AG	Increased	1,748(+218x)	$1,245	0.0%	+9.27%	12

SCINAI IMMUNOTHERAPEUTICS LT SPONSO

Continue exploring